Skip to main content
. 2015 Sep 18;42(2):358–368. doi: 10.1093/schbul/sbv133

Table 1.

Description of Study Sample: Patients, Siblings, and Controls

Variable Patients (N = 215) Siblings (N = 187) Controls (N = 98) χ2 or F P
Gender: Male, % 84.2 42.8 62.2 75.0 <.001
Age, mean (SD) 26.3 (7.6) 27.6 (8.5) 27.6 (10.4) 1.4 .256
Ethnicitya (%)
 European 63.7 74.3 77.6 14.0 .30
 North-African 4.2 3.2 5.1
 Surinamese 4.2 3.7 3.1
 Turkish 3.3 3.7 0
 Dutch Caribbean 0.9 0 0
 Mixed 14.4 11.2 6.1
 Other 2.8 1.6 3.1
IQb mean (SD) 94.1 (16.2) 102.9 (14.6) 105.8 (16.3) 23.9 <.001
BMIc mean (SD) 24.2 (4.6) 23.0 (3.4) 22.5 (2.8) 8.2 <.001
Cannabisd
Urine positive % 17.7 7.0 8.2 11.7 .003
Tobaccoe
Daily/12 mo.% 66.0 33.7 26.5 63.4 <.001

aMissings patients, siblings, controls (%): 6.5; 2.1; 5.0

bIQ = Intelligence Quotient

Missings patients, siblings, controls (%): 7.0; 9.0; 4.0

cBMI = Body Mass Index

Missings patients, siblings, controls (%): 9.3; 10.0; 4.1

dMissings patients, siblings, controls (%): 7.4; 9.6; 13.3

eMissings patients, siblings, controls (%): 3.7; 3.2; 4.1